AMICUS THERA (NASDAQ:FOLD)
3.83
0.15 (3.77%)
| AMICUS THERA (NASDAQ:FOLD) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.98 | 52 Week High | $13.50 | ||
| Open | $3.94 | 52 Week Low | $3.68 | ||
| Day High | $4.03 | P/E | N/A | ||
| Day Low | $3.76 | EPS | $-2.37 | ||
| Volume | 41,823 | ||||
| More FOLD Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| DEPO | 3 | FTBK | 2 |
| OPTV | 2 | REED | 2 |
| AVII | 2 | SCLN | 2 |
| SGEN | 2 | CRXX | 2 |
| VG | 1 | AET | 1 |
| ARG | 1 | BELFB | 1 |
Entities who have mentioned FOLD
- Carl Icahn | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- JPMorgan | View Related Stories »
- Deutsche Bank | View Related Stories »
- Lazard | View Related Stories »
- 13G | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- Needham & Co | View Related Stories »
- Wedbush Morgan | View Related Stories »
- Palo Alto Investors | View Related Stories »
- UBS | View Related Stories »
- Morgan Stanley | View Related Stories »
- Dividend | View Related Stories »
- Layoffs | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
View All Major News StreetInsider.com Major News for FOLD
- Amicus Therapeutics (FOLD) Reports Better-Than-Expected Q2 Adj-Loss of $0.51
- Amicus Therapeutics (FOLD) Reports Smaller Than Expected Q1 Loss; Revs Light
- Amicus Therapeutics (FOLD) Tops Q4 EPS by 7c, Comments on FY09
View All ReportsStreetInsider.com Reports on FOLD
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- Unusual 11 Mid-Day Movers 10/05: ROIAK, DEPO, AVII, CMLS Higher; FOLD, SGEN, SCLN, REED Lower
- Lazard Capital Downgrades Amicus Therapeutics (FOLD) to Hold
- Wedbush Morgan Downgrades Amicus Therapeutics (FOLD) to Underperform; Slashes PT
- Morning Movers 10/05: DEPO, AVII, OPTV, CRXX, UCTT, CPRX Higher; FOLD, FTBK, SGEN, SCLN, REED Lower
View All Press ReleasesCompany Press Releases on FOLD
- Amicus Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
- Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors
- Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
- Amicus Therapeutics Announces Third Quarter 2009 Financial Results Release Date
- Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
StreetInsider Reports on FOLD by Category
View All BlogsBlogs on FOLD
- Developments for Parkinson's Disease Ignite Investor Enthusiasm
- Trial Setback Is Welcome News for Genzyme, But Don't Get Too Excited
- Closing Bell: The bull returns ahead of earnings (GE, WFC, FOLD, CIEN, VG)
- Sell Genzyme Near Term Due to Challenges with Manufacturing Biologics
- Sell Genzyme Near Term Due to Continued Manufacturing Challenges
View All FilingsSEC Filings on FOLD
- Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: John McAdam M
- Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Kirk John
- Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Campbell Bradley L
- Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Gilmore Geoffrey
- Form 4 AMICUS THERAPEUTICS INC For: Nov 16 Filed by: Schaeffer Orlov S Nicole
Comments on FOLD
No comments are currently available.
